NCT00825942Unknown2 期
An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Reduction in the number of asteroid bodies
研究概览
简要总结
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Presence of asteroid hyalosis
排除标准
- •Active ocular infection
- •Ocular hypertension
- •Ocular inflammatory disorders
研究组 & 干预措施
C-KAD Ophthalmic Solution
Experimental
干预措施: C-KAD Ophthalmic Solution (Drug)
结局指标
主要结局
Reduction in the number of asteroid bodies
时间窗: 180
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular HypertensionOcular HypertensionNCT00825396Chakshu Research, Inc.12
Unknown
2 期
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related CataractCataractNCT00793091Chakshu Research, Inc.80
Unknown
2 期
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear CataractNuclear CataractNCT00825721Chakshu Research, Inc.81
已完成
2 期
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry EyeDry EyeNCT03676335Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.240
已完成
3 期
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseDry EyeNCT04541888Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.644